Howard Young

Howard Young is currently the VP of Finance at Clade Therapeutics since September 2022. Prior to this, Howard held similar roles at BlueRock Therapeutics, LifeMine Therapeutics, and FogPharma. With a background in finance and business development, Howard has also worked at companies such as Boston Biomedical, Vertex Pharmaceuticals, and Woomera Therapeutics. Howard obtained an MBA from The Tuck School of Business at Dartmouth and an A.B. from Middlebury College.